Rachel Schneerson

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, National Research Council of Canada, New York University. Active years: 1993-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel Schneerson. Retrieved from https://idiyas.com/inventor/rachel-schneerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 7)

% Patents Active = 37.0

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 118(Granted Patents)

Company Filing History:

24 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4 out of 1,039

National Research Council of Canada

The United States of America as Represented by the Department of Health

patents

5. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2017

Loading Chart...

Areas of Expertise:

Malaria Vaccine

Immunogenic Conjugates

Influenza Virus

Polysaccharide-Protein Conjugates

Glycoconjugate Vaccine

Immune Responses

Carrier Proteins

Oligosaccharides

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9845350 - [object Object] (2017-12-19),

2. 9273124 - [object Object] (2016-03-01),

3. 9144604 - [object Object] (2015-09-29),

4. 9096653 - Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia (2015-08-04),

5. 8926986 - [object Object] (2015-01-06),

6. 8900599 - [object Object] (2014-12-02),

7. 8795680 - Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid (2014-08-05),

8. 8747863 - Vaccine for shigella (2014-06-10),

9. 8703150 - [object Object] (2014-04-22),

10. 8658180 - Vaccines against influenza virus (2014-02-25),

11. 8501182 - [object Object] (2013-08-06),

12. 8481048 - Methods for preparing immunogenic conjugates (2013-07-09),

13. 8444996 - Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia (2013-05-21),

14. 8394387 - [object Object] (2013-03-12),

15. 8383133 - [object Object] (2013-02-26),

Title: Rachel Schneerson - The Innovative Inventor from Bethesda

Introduction: Rachel Schneerson is a pioneering inventor known for her groundbreaking contributions to the field of medicine and public health. Born in Bethesda, MD, she has dedicated her career to developing innovative solutions to improve global healthcare.

Latest Patents: Rachel Schneerson holds several patents related to vaccines and immunology, with her most recent patent focusing on a novel approach to vaccine delivery for infectious diseases.

Career Highlights: Throughout her illustrious career, Rachel Schneerson has worked tirelessly to advance the field of vaccinology. She is renowned for her role in the development of the Haemophilus influenzae type b (Hib) vaccine, which has saved countless lives worldwide.

Collaborations: Rachel Schneerson has collaborated with leading research institutions, pharmaceutical companies, and public health organizations to further her research and bring her innovative ideas to fruition. Her collaborative spirit has been instrumental in the success of her projects.

Conclusion: Rachel Schneerson's dedication to innovation and her passion for improving global health make her a true trailblazer in the field of medicine. Her pioneering work continues to have a lasting impact on healthcare practices around the world.

Profile summary based on public USPTO records.